|
1
|
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection.
|
EMBO J
|
1989
|
3.65
|
|
2
|
In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.
|
J Virol
|
1991
|
2.54
|
|
3
|
ICP34.5 influences herpes simplex virus type 1 maturation and egress from infected cells in vitro.
|
J Gen Virol
|
1994
|
1.50
|
|
4
|
Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10.
|
Euro Surveill
|
2010
|
1.34
|
|
5
|
A herpes simplex virus type 1 variant, deleted in the promoter region of the latency-associated transcripts, does not produce any detectable minor RNA species during latency in the mouse trigeminal ganglion.
|
J Gen Virol
|
1990
|
1.23
|
|
6
|
The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34.
|
J Virol
|
1997
|
1.16
|
|
7
|
The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice.
|
J Gen Virol
|
1994
|
1.15
|
|
8
|
Herpes simplex virus type 1 gene UL14: phenotype of a null mutant and identification of the encoded protein.
|
J Virol
|
2000
|
1.12
|
|
9
|
Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2.
|
J Gen Virol
|
1994
|
1.11
|
|
10
|
A herpes simplex virus type 1 variant which fails to synthesize immediate early polypeptide VmwIE63.
|
J Gen Virol
|
1987
|
1.05
|
|
11
|
Characterization of the herpes simplex virus type 1 strain 17+ neurovirulence gene RL1 and its expression in a bacterial system.
|
J Gen Virol
|
1994
|
1.05
|
|
12
|
Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant.
|
Lab Invest
|
1995
|
1.05
|
|
13
|
Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17.
|
J Gen Virol
|
1992
|
1.04
|
|
14
|
Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716.
|
J Gen Virol
|
1992
|
1.04
|
|
15
|
Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model.
|
J Gen Virol
|
1995
|
1.04
|
|
16
|
A model of chronic nerve compression in the rat.
|
Ann Plast Surg
|
1987
|
1.02
|
|
17
|
Analysis of intrastrain recombination in herpes simplex virus type 1 strain 17 and herpes simplex virus type 2 strain HG52 using restriction endonuclease sites as unselected markers and temperature-sensitive lesions as selected markers.
|
J Gen Virol
|
1992
|
1.01
|
|
18
|
Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy.
|
Br J Cancer
|
1996
|
0.99
|
|
19
|
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma.
|
Cancer Res
|
1997
|
0.99
|
|
20
|
Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors.
|
Gene Ther
|
1996
|
0.98
|
|
21
|
The herpes simplex virus type 1 strain 17 open reading frame RL1 encodes a polypeptide of apparent M(r) 37K equivalent to ICP34.5 of herpes simplex virus type 1 strain F.
|
J Gen Virol
|
1993
|
0.90
|
|
22
|
High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5.
|
Gene Ther
|
1998
|
0.89
|
|
23
|
Histopathological responses in the CNS following inoculation with a non-neurovirulent mutant (1716) of herpes simplex virus type 1 (HSV 1): relevance for gene and cancer therapy.
|
Neuropathol Appl Neurobiol
|
1998
|
0.87
|
|
24
|
Identification and characterization of the protein product of gene 71 in equine herpesvirus 1.
|
J Gen Virol
|
1994
|
0.86
|
|
25
|
Generation of a herpes simplex virus type 1 variant devoid of XbaI sites.
|
J Gen Virol
|
1987
|
0.86
|
|
26
|
Functional analysis of the herpes simplex virus type 2 strain HG52 RL1 gene: the intron plays no role in virulence.
|
J Gen Virol
|
1998
|
0.85
|
|
27
|
Monitoring induction of ovulation by rapid radioimmunoassays of oestrogen and pregnanediol glucuronides.
|
Ann Clin Biochem
|
1981
|
0.83
|
|
28
|
Replication of the herpes simplex virus type 1 RL1 mutant 1716 in primary neuronal cell cultures--possible relevance to use as a viral vector.
|
J Neurol Sci
|
2000
|
0.83
|
|
29
|
Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors.
|
Gene Ther
|
1996
|
0.83
|
|
30
|
The role of the gene 71 product in the life cycle of equine herpesvirus 1.
|
J Gen Virol
|
1996
|
0.80
|
|
31
|
Sequence analysis of the herpes simplex virus type 1 strain 17 variants 1704, 1705 and 1706 with respect to their origin and effect on the latency-associated transcript sequence.
|
J Gen Virol
|
1991
|
0.79
|
|
32
|
The herpes simplex virus type 2 strain HG52 RL1 gene contains a 154 bp intron as predicted from sequence analysis.
|
J Gen Virol
|
1996
|
0.79
|
|
33
|
Identification and characterization of the protein product of gene 67 in equine herpesvirus type 1 strain Ab4.
|
J Gen Virol
|
1995
|
0.78
|
|
34
|
Letter to the editor: There is a need to consider all respiratory viruses in suspected mumps cases.
|
Euro Surveill
|
2015
|
0.75
|
|
35
|
Ileocaecal junction carcinoma: a clinicopathological study of 199 cases.
|
Colorectal Dis
|
2015
|
0.75
|